Liang Y, Gao H, Lin S-Y, Goss J A, Du C, Li K
1] The Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA [2] School of Pharmaceutical Sciences, Taishan Medical University, Tai'an, Shandong, China.
The Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Oncogene. 2015 Aug 13;34(33):4368-78. doi: 10.1038/onc.2014.367. Epub 2014 Nov 3.
MCPH1, also known as BRIT1, has recently been identified as a novel key regulatory gene of the DNA damage response pathway. MCPH1 is located on human chromosome 8p23.1, where human cancers frequently show loss of heterozygosity. As such, MCPH1 is aberrantly expressed in many malignancies, including breast and ovarian cancers, and the function of MCPH1 has been implicated in tumor suppression. However, it remains poorly understood whether MCPH1 deficiency leads to tumorigenesis. Here we generated and studied both Mcph1(-/-) and Mcph1(-/-)p53(-/-) mice; we showed that Mcph1(-/-) mice developed tumors with long latency, and that primary lymphoma developed significantly earlier in Mcph1(-/-)p53(-/-) mice than in Mcph11(+/+)p53(-/-) and Mcph1(+/-)p53(-/-) mice. The Mcph1(-/-)p53(-/-) lymphomas and derived murine embryonic fibroblasts (MEFs) were both more sensitive to irradiation. Mcph1 deficiency resulted in remarkably increased chromosome and chromatid breaks in Mcph1(-/-)p53(-/-) lymphomas and MEFs, as determined by metaphase spread assay and spectral karyotyping analysis. In addition, Mcph1 deficiency significantly enhanced aneuploidy as well as abnormal centrosome multiplication in Mcph1(-/-)p53(-/-) cells. Meanwhile, Mcph1 deficiency impaired double strand break (DSB) repair in Mcph1(-/-)p53(-/-) MEFs as demonstrated by neutral Comet assay. Compared with Mcph1(+/+)p53(-/-) MEFs, homologous recombination and non-homologous end-joining activities were significantly decreased in Mcph1(-/-)p53(-/-) MEFs. Notably, reconstituted MCPH1 rescued the defects of DSB repair and alleviated chromosomal aberrations in Mcph1(-/-)p53(-/-) MEFs. Taken together, our data demonstrate MCPH1 deficiency promotes genomic instability and increases cancer susceptibility. Our study using knockout mouse models provides convincing genetic evidence that MCPH1 is a bona fide tumor suppressor gene. Its deficiency leading to defective DNA repair in tumors can be used to develop novel targeted cancer therapies in the future.
MCPH1,也被称为BRIT1,最近被确定为DNA损伤反应通路的一个新的关键调控基因。MCPH1位于人类8号染色体p23.1区域,该区域在人类癌症中经常出现杂合性缺失。因此,MCPH1在包括乳腺癌和卵巢癌在内的许多恶性肿瘤中异常表达,并且MCPH1的功能与肿瘤抑制有关。然而,MCPH1缺陷是否导致肿瘤发生仍知之甚少。在这里,我们构建并研究了Mcph1(-/-)和Mcph1(-/-)p53(-/-)小鼠;我们发现Mcph1(-/-)小鼠发生肿瘤的潜伏期很长,并且Mcph1(-/-)p53(-/-)小鼠原发性淋巴瘤的发生明显早于Mcph11(+/+)p53(-/-)和Mcph1(+/-)p53(-/-)小鼠。Mcph1(-/-)p53(-/-)淋巴瘤及其衍生的小鼠胚胎成纤维细胞(MEF)对辐射都更敏感。通过中期铺展分析和光谱核型分析确定,Mcph1缺陷导致Mcph1(-/-)p53(-/-)淋巴瘤和MEF中的染色体和染色单体断裂显著增加。此外,Mcph1缺陷显著增强了Mcph1(-/-)p53(-/-)细胞中的非整倍体以及异常中心体增殖。同时,中性彗星试验表明,Mcph1缺陷损害了Mcph1(-/-)p53(-/-)MEF中的双链断裂(DSB)修复。与Mcph1(+/+)p53(-/-)MEF相比,Mcph1(-/-)p53(-/-)MEF中的同源重组和非同源末端连接活性显著降低。值得注意的是,重组的MCPH1挽救了Mcph1(-/-)p53(-/-)MEF中的DSB修复缺陷并减轻了染色体畸变。综上所述,我们的数据表明MCPH1缺陷促进基因组不稳定并增加癌症易感性。我们使用基因敲除小鼠模型的研究提供了令人信服的遗传学证据,证明MCPH1是一个真正的肿瘤抑制基因。其缺陷导致肿瘤中DNA修复缺陷,未来可用于开发新的靶向癌症治疗方法。
DNA Repair (Amst). 2013-5-15
Proc Natl Acad Sci U S A. 2006-2-28
Nucleic Acids Res. 2020-9-18
Cell Death Differ. 2020-9
Cells. 2024-11-17
Front Oncol. 2023-1-31
Cells. 2022-1-14
Int J Mol Sci. 2021-10-1
Nucleic Acids Res. 2020-9-18
Eur J Cell Biol. 2014-1-29
Asian Pac J Cancer Prev. 2013
PLoS One. 2013-8-19
Carcinogenesis. 2013-6-1
Nat Rev Genet. 2012-1-24